Characteristics of the binding of tacrine to acidic phospholipids

Biophysical Journal

Volumn 70, Issue 5, 1996, Pages 2185-2194

  Lehtonen, Jukka Y A ^a   Rytömaa, Marjatta ^a   Kinnunen, Paavo K J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLGLYCEROL; LIPOSOME; PHOSPHOLIPID; TACRINE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CONCENTRATION RESPONSE; DRUG BINDING; ENTHALPY; MEMBRANE BINDING; POLARIZATION; STOICHIOMETRY; SURFACE CHARGE; TEMPERATURE DEPENDENCE;

EID: 0030007501     PISSN: 00063495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3495(96)79784-9     Document Type: Article

References (66)

1. Adern, A. 1992. Putative mechanism of action of tacrine in Alzheimer's disease. Acta Neurol. Scand. Suppl. 139:69-74.
2. Arispe, N., H. B. Pollard, and E. Rojas. 1993. Giant multilevel cation channels formed by Alzheimer disease amyloid β-protein [AβP-(1-40)] in bilayer membranes. Proc Natl. Acad. Sci. USA. 90:10573-10577.
3. 2H NMR study. Biochemistry. 27:4660-4667.
4. Barthel, D., O. Zschoernig, K. Lange, R. Lenk, and K. Arnold. 1988. Interaction of electrically charged drug molecules with phospholipid membranes. Biochim. Biophys. Acta. 945:361-366.
5. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466-468.
6. Bauerle, H.-D., and J Seelig. 1991. Interaction of charged and uncharged calcium channel antagonists with phospholipid membranes. Binding equilibrium, binding enthalpy, and membrane location. Biochemistry. 30:7203-7211.
7. Berclaz, T., and M. Geoffrey. 1984. Spin-labeling study of phosphatidylcholine-cardiolipin binary mixtures. Biochemistry. 23:4033-4037.
8. Berclaz, T., and H. M. McConnell. 1981. Phase equilibrium in binary mixtures of DMPC and cardiolipin. Biochemistry. 20:6635-6640.
9. Callaghan, R., A. Stafford, and R. M. Epand 1993. Increased accumulation of drugs in multidrug resistant cell line by alteration of membrane biophysical properties. Biochim. Biophys. Acta. 1175:277-282.
10. Canaves, J. M., J. A. Ferragut, and J. M. Gonzalez-Ros. 1991. Verapamil prevents the effects of daunomycin on the thermotropic phase transition of model bilayers. Biochem. J. 279:413-418.
11. Cao, A., E. Hantz-Brachet, B. Azize, E. Taillandier, and G. Perret. 1991. The interaction of D-propranolol and dimyristoyl phosphatidylcholine large unilamellar vesicles investigated by quasielastic light scattering and Fourier-transform infrared spectroscopy. Chem. Phys. Lipids. 58: 225-232.
12. Carruthers, A., and D. L. Melchior 1986. How bilayer lipids affect membrane protein activity. Trends Biochem. Sci. 11:331-335.
13. Chong, P. L-G 1994. Evidence for regular distribution of sterols in liquid crystalline phosphatidylcholine bilayers. Proc. Natl. Acad. Sci. USA. 91:10069-10073.
14. Chong, P. L-G., D. Tang, and I. P. Sugar. 1994. Exploration of physical principles underlying lipid regular distribution: effects of pressure, temperature, and radius of curvature on E/M dips in pyrene-labelled PC/ DMPC binary mixtures. Biophys. J. 66:2029-2038.
15. Cornea, R. L., and D. D. Thomas. 1994. Effects of membrane thickness on the molecular dynamics and enzymatic activity of reconstituted Ca-ATPase. Biophys. J. 33:2912-2920.
16. Dell'Antone, P., M. Bragadin, and P. Zatta. 1995. Anticholinesterasic drugs: tacrine but not physostigmine, accumulates in acidic compartments of the cells. Biochim. Biophys. Acta. 1270:137-141.
17. de Young, L. R., and K. A. Dill. 1988. Solute partitioning into lipid bilayer membranes Biochemistry. 27:5281-5289.
18. Eibl, H., and P. Woolley. 1979. Electrostatic interactions at charged lipid membranes. Hydrogen bonding in lipid membrane surfaces. Biophys. Chem. 10:261-271.
19. Escriba, P. V., A. V. Ferrer-Montiel, J. A. Ferragut, and J. M. Gonzalez-Ros. 1990. Role of membrane lipids in the interaction of daunomycin with plasma membranes from tumor cells, implications in drug-resistance phenomena. Biochemistry. 29:7275-7282.
20. Goormaghtigh, E., and J. M. Ruysschaert. 1984. Anthracycline glycoside-membrane interactions. Biochim. Biophys. Acta. 779:271-288.
21. Hanpft, R., and K. Mohr. 1985. Influence of cationic amphiphilic drugs on the phase-transition temperature of phospholipids with different polar headgroups. Biochim. Biophys. Acta. 814:156-162.
22. Henry, N , E O. Fantine, J. Bolard, and A. Garnier-Suillerot. 1985. Interaction of adriamycin with negatively charged model membranes: evidence for two types of binding sites. Biochemistry. 24:7085-7092.
23. Herbette, L. G., D. W. Chester, and D. G. Rhodes. 1986. Structural analysis of drug molecules in biological membranes. Biophys. J. 49:91-94.
24. Herbette, L. G., A. M. Katz, and J. M. Sturtevant. 1983. Comparisons of the interaction of propranolol and timolol with model and biological membrane systems Mol. Pharmacol. 24:259-269.
25. Ito, S., D. K. Werth, N. D. Richert, and I. Pastan. 1983. Vinculin phosphorylation by the src kinase. Interaction of vinculin with phospholipid vesicles. J. Biol. Chem. 258:14626-14631.
26. Kaminoh, Y., H. Kamaya, and I. Ueda. 1989. Differential affinity of charged local anesthetics to solid-gel and liquid-crystalline states of dimyristoylphosphatidic acid vesicle membranes. Biochim. Biophvs. Acta. 987:63-68.
27. Kinnunen, P. K. J., A. Koiv, and P. Mustonen. 1993. Pyrene-labelled lipids as fluorescent probes in studies on biomembranes and membrane models. In Fluorescence Spectroscopy. O. S. Wolfbeis, editor. Springer-Verlag, Berlin. 159-169.
28. Kinnunen, P. K. J., A. P. Tulkki, H. Lemmetyinen, J. Paakkola, and J. A. Virtanen. 1987. Characteristics of excimer formation in Langmuir-Blodgett assemblies of 1-palmitoyl-2-pyrenedecanoyl- and 1,2-dipalmitoyl-phosphatidylcholine. Chem. Phys. Lett. 136:539-545.
29. Kunze, H., N. Nahas, J. R. Traynor, and M. Wurl. 1976. Effects of local anesthetics on phospholipases. Biochim. Biophys. Acta. 441:93-102.
30. Lakowicz, J. R. 1983. Fluorescence polarization. In Principles of Fluorescence Spectroscopy. Plenum Press, New York. 112-151.
31. Lieber. M. R., Y. Lange, R. S. Weinstein, and T. L. Steck. 1984. Interaction of chlorpromazine with the human erythrocyte membrane. J. Biol. Chem. 259:9225-9234.
32. Luxnat, M., and H.-J. Galla. 1986. Partition of chlorpromazine into bilayer membranes: the effect of membrane structure and composition. Biochim. Biophys. Acta. 856:274-282.
33. Mabrey, S., P. L. Mateo, and J. M. Sturtevant. 1978. High-sensitivity scanning calorimetric study of mixtures of cholesterol with dimyristoyl- and dipalmitoylphosphatidylcholines. Biochemistry. 17:2464-2468.
34. MacDonald, R. C., R. I. MacDonald, B. M. Menco, K. Takeshita, N. K. Subbarao, and L. R. Hu. 1991. Small-volume extrusion apparatus for preparation of large unilamellar vesicles. Biochim. Biophys. Acta. 1061: 297-303.
35. Marotta, C. A., R. E. Majocha, and B. Tate. 1992. Molecular and cellular biology of Alzheimer amyloid. J. Mol. Neurosci. 3:111-125.
36. 2 by adriamycin in vitro: role of drug/lipid interactions. J. Biol. Chem. 266:6302-6307.
37. Mustonen, P., and P. K. J. Kinnunen. 1993. On the reversal by deoxyri-bonucleic acid of the binding of adriamycin to cardiolipin-containing liposomes. J. Biol. Chem. 268:1074-1080.
38. 2. Biochemistry. 32: 5373-5380.
39. Mustonen, P., J. A. Virtanen, P. J. Somerharju, and P. K. J. Kinnunen. 1987. Binding of cytochrome c to liposomes as revealed by the quenching of fluorescence from pyrene-labelled phospholipids. Biochemistry. 26:2991-2997.
40. Olson, F., C. A. Hunt, F. C. Szonka, W. J. Vail, and D. Papahadjopoulos. 1979. Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim. Biophys. Acta. 557:9-23.
41. Recktenwald, D. J., and H. M. McConnell. 1981. Phase equilibria in binary mixtures of phosphatidylcholines and cholesterol. Biochemistry. 20: 4505-4510.
42. Rhodes, D. G., R. Newton, R. Butler, and L. G. Herbette. 1992. Equilibrium and kinetic studies of the binding of salmeterol with membrane bilayers. Mol. Pharmacol. 41:596-602.
43. Rhodes, D. G., J. G. Sarmiento, and L. G. Herbette. 1985. Kinetics of binding of membrane active drugs to receptor sites. Diffusion-limited rates for a membrane bilayer approach of 1,4-dihydropyridine calcium channel antagonists to their active site. Mol. Pharmacol. 27:612-623.
44. Rubenstein, J. L. R., J. C. Owicki, and H. M. McConnell. 1980. Dynamic properties of phosphatidylcholines and cholesterol. Biochemistry. 19: 569-573.
45. Rubenstein, J. L. R., B. A. Smith, and H. M. McConnell. 1979. Lateral diffusion in binary mixtures of cholesterol and phosphatidylcholines. Proc. Natl. Acad. Sci. USA. 76:15-18.
46. Sargent, D. F., and R. Schwyzer. 1986. Membrane lipid phase as catalyst for peptide-receptor interactions. Proc. Natl Acad. Sci. USA. 83: 5774-5778.
47. Seelig, A., P. R. Allegrini, and J. Seelig. 1988. Partitioning of local anesthetics into membranes: surface charge effects monitored by the phospholipid headgroup. Biochim. Biophys. Acta. 939:267-276
48. Seelig, J., and P. Ganz. 1991. Nonclassical hydrophobic effect in membrane binding equilibria. Biochemistry. 30:9354-9359.
49. Siegfried, J. A., K. A. Kennedy, A. C. Sartorelli, and T. T. Tntton. 1983. The role of membranes in the mechanism of action of the antineoplastic agent adriamycin. Spin-labeling studies with chronically hypoxic and drug-resistant tumor cells. J. Biol. Chem. 258:339-343.
50. Sisodia, S. S., and D. L. Price. 1995. Role of the β-amyloid protein in Alzheimer's disease. FASEB J. 9:366-370.
51. Somerharju, P., J. A. Virtanen, K. K. Eklund, P. Vainio, and P. K. J. Kinnunen. 1985. 1-Palmitoyl-2-pyrenedecanoyl glycerophospholipids as membrane probes: evidence for regular distribution in liquid-crystalline phosphatidylcholine bilayers. Biochemistry. 24:2773-2781.
52. Soreghan, B., J. Kosmoski, and C. Glabe. 1994. Surfactant properties of Alzheimer's Aβ peptides and the mechanism of amyloid aggregation. J. Biol. Chem. 269:28551-28554.
53. Sugar, I. P., D. Tand, and P. L.-G. Chong. 1994. Monte Carlo simulation of lateral distribution of molecules in two component membrane. Effect of long range repulsion interactions. J. Phys. Chem. 98:7201-7210.
54. Tang, D., and P. L.-G. Chong. 1992. A/M dips: evidence for lipids regularly distributed into hexagonal super-lattices in pyrene-PC/DMPC binary mixtures at specific concentrations. Biophys. J. 63:903-310.
55. Tang, D., B. W. Van Der Meer, S.-Y. S. Chen. 1995. Evidence for a regular distribution of cholesterol in phospholipid bilayers from diphenylhexatriene fluorescence. Biophys. J. 68:1944-1951.
56. Terzi, E., H. Holzemann, and J. Seelig. 1994. Alzheimers amyloid peptide 25-35: electrostatic interactions with phospholipid membranes. Biochemistry. 33:7434-7441.
57. 2 in serum. Clin. Chem. 31: 714-717.
58. Tritton, T. R., and G. Yee. 1982. The anticancer agent adriamycin can be actively cytotoxic without entering cells. Science. 217:248-250.
59. Tsai, Y.-S., S.-M. Ma, H. Kamaya, and I. Ueda. 1987. Fourier transform infrared studies on phospholipid hydration: phosphate-oriented hydrogen bonding and its attenuation by volatile anesthetics. Mol. Pharmacol. 31:623-630.
60. Virtanen, J. A., P. Somerharju, and P. K. J. Kinnunen. 1988. Prediction of patterns for the regular distribution of saluted guest molecules in liquid crystalline phospholipid membranes. J. Molec. Electronics. 4:233-236.
61. Xiao. W. B., A. Nordberg, and X. Zhang. 1993. Effect of in vivo microdialysis of 1,2,3,4-tetrahydro-9-acridinamine monohydrate (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. J. Pharmacol. Exp. Ther. 265:759-764.
62. Yanagisawa, K., A. Odaka, N. Suzuki, and Y. Ihara. 1995 GM1 ganglioside-bound amyloid β-protem (Aβ): a possible form of preamyloid in Alzheimer's disease. Nature Med. 1:1062-1066.
63. Young, H. S., V. Skita, R P. Mason, and L. G. Herbette. 1992. Molecular basis for the inhibition of 1,4-dihydropyridine calcium channel drugs binding to their receptors by nonspecific site interaction mechanism. Biophys. J. 61:1244-1255.
64. Wadkins, R. M., and P. J. Houghton. 1993. The role of drug-lipid interactions in the biological activity of modulators of multi-drug resistance. Biochim Biophys. Acta. 1153:225-236.
65. White, S. H., and W. C. Wimley 1994. Peptides in lipid bilayers: structural and thermodynamic basis for partitioning and folding. Curr. Opin. Struct. Biol. 4:79-86.
66. Wright, S. E., and J. C. White. 1986. Membrane ordering effect of the anticancer agent VM-26. Biochim. Biophys. Acta. 863:297-304.